10/6/2021Anixa Biosciences Announces First Chinese Patent on its CAR-T Cancer T...

10/6/2021Nature: China's Data-driven Dream to Overhaul Healthcare

10/5/2021NH Reports MAT 06/2021 Data on the Chinese Cough, Cold and Allergy Mar...

10/5/2021Recent Developments with A New Round of NEDL Revision

10/4/2021China to Adopt Patient Reported Outcome Technology to Supplement Clini...

10/4/2021LianBio Files for IPO, Plans to Apply for Nasdaq Listing

10/4/2021Kintor Pharma Announces First Patient Dosing in Phase III Trial of Pro...

9/30/2021NMPA Applies for Pre-accession to PIC/S    

9/30/2021NMPA Issues the Announcement on eCTD Implementation

9/30/2021Financial-related Company News in Brief

9/30/2021Recent Executive Moves

9/30/2021Luye Pharma Granted Chinese IND Approval for Class 1 New Drug LY03015

9/30/2021CBMG Holdings Completes $120 Million in Series A Funding

9/30/2021Biden Admin Urged by Congressional Members to Blacklist BGI and Select...

9/30/2021China Upholds Healthcare Cost Containment as It Seeks to Enhance Acces...

9/29/2021IQVIA: Chinese Retail Pharmacy Sales Up 0.9% in Q2/2021

9/29/2021PhIIC: Chinese Hospital Drugs Sales Jumps 17.9% in H1 after Decline La...

9/29/2021SMEI: Chinese Hospital Chemical Drug Sales Rebounded 17.83% in H1 Led ...

9/29/2021State Council Issues the 14th Five Year Plan for Universal Healthcare ...

9/29/2021Bloomberg: I-Mab Eyes Biopharma Partnerships, Possible Equity Sale

9/29/2021HUTCHMED Closes Divestment of Non-Core Chinese OTC Joint Venture

9/29/2021Zhaoke Ophthalmology's Chinese IND for Potential First Myopia Drug NVK...

9/29/2021iX Biopharma Enters Deal with China Resources Pharma for ED Drug Wafe...

9/28/2021JW Therapeutics Granted Chinese Approval of T-Cell Therapy for Large B...

9/28/2021NHSA Completes Expert Review of Product Applications for 2021 NRDL

9/28/2021Cyclica and IMPACT Therapeutics Team Up to Advance Differentiated Anti...

9/28/2021I-Mab's Chinese IND Accepted for P2 Trial of Enoblituzumab in Combo wi...

9/28/2021Genelux and Newsoara Announce License Deal for Oncolytic Immunotherapi...

9/28/2021China's "Hatch-Waxman" System: A Comparative Overview

9/27/2021CDE Solicits Public Comments on Draft of the Technical Guidelines for ...

Page:190/797 Total number of articles:23898: [First][<<] [188] [189] [190] [191] [192] [>>] [End]